Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Lara Dimick-Santos"'
Autor:
Claudia M. Filozof, Carolin Lackner, Manuel Romero-Gómez, Joanne C. Imperial, Robert McGee, Lara Dimick-Santos, Oscar Cummings, Cynthia Behling, Troy Johnson, Arun Sanyal
Publikováno v:
GastroHep. 2022:1-11
Background. In most clinical trials focusing on precirrhotic nonalcoholic steatohepatitis (NASH), a liver biopsy is required for confirmation of diagnosis, staging fibrosis, and grading steatohepatitis activity. Reliance on the biopsy, both as a requ
Autor:
Denise Coffey, Ann Marie Stanley, Liliam Pineda-Salgado, Don C. Rockey, Meenal Patwardhan, Melissa Palmer, Raúl J. Andrade, Ritu Raheja, John Caminis, Sandzhar Abdullaev, Lara Dimick-Santos, David L. Bourdet, Paul H. Hayashi, Daniel Seekins, J. Hey-Hadavi, Haifa Tyler, Alvin Estilo
Publikováno v:
Drug Safety
Causality assessment for suspected drug-induced liver injury (DILI) during drug development and following approval is challenging. The IQ DILI Causality Working Group (CWG), in collaboration with academic and regulatory subject matter experts (SMEs),
Publikováno v:
Drug Safety. 43:1267-1276
Ulipristal acetate (ulipristal) is a selective progesterone receptor modulator that has been marketed for daily use in Europe and Canada to reduce symptoms caused by uterine fibroids. Long-term use of some other members of this class of 19-norprogest
Autor:
Frank A. Anania, John Marcinak, Mark I. Avigan, Arun J. Sanyal, Melissa Palmer, Gopal Krishna, Lara Dimick-Santos, Daniel Seekins, Arie Regev, James H. Lewis, Naga Chalasani, William R. Treem, James W. Freston
Publikováno v:
Alimentary Pharmacology & Therapeutics
Background The last decade has seen a rapid growth in the number of clinical trials enrolling patients with nonalcoholic fatty liver disease and nonalcoholic steatohepatitis (NASH). Due to the underlying chronic liver disease, patients with NASH ofte
Publikováno v:
Hepatology (Baltimore, Md.)References. 73(5)
Autor:
I. Lonjon-Domanec, Lara Dimick-Santos, John Marcinak, James W. Freston, Raúl J. Andrade, Mark I. Avigan, James H. Lewis, Adrian M. Di Bisceglie, Melissa Palmer, Daniel Seekins, Don C. Rockey, Meenal Patwardhan, Ajit Dash, Arie Regev, E Maller, Naga Chalasani, William R. Treem
Publikováno v:
Drug Safety
With the widespread development of new drugs to treat chronic liver diseases (CLDs), including viral hepatitis and nonalcoholic steatohepatitis (NASH), more patients are entering trials with abnormal baseline liver tests and with advanced liver injur
Autor:
S. Megnien, Mohammad S. Siddiqui, Laurent Castera, Katherine Greene, Veronica Miller, Elmer Schabel, David E. Kleiner, Manal F. Abdelmalek, Arun J. Sanyal, Stephen A. Harrison, Scott L. Friedman, Quentin M. Anstee, Vlad Ratziu, Pierre Bedossa, Brent A. Neuschwander-Tetri, Lara Dimick-Santos
Publikováno v:
Hepatology (Baltimore, Md.)
Nonalcoholic steatohepatitis (NASH) is an important cause of liver-related morbidity and mortality. There are no approved therapies, and the results of clinical trials have been difficult to compare due to inconsistent definitions of relevant disease
Autor:
Lara Dimick-Santos, Shein-Chung Chow, Barry J. Goldstein, Arun J. Sanyal, Yeh-Fong Chen, Claudia Filozof, Richard N. Williams
Publikováno v:
Hepatology Communications
Due to the increasing prevalence of nonalcoholic steatohepatitis (NASH) and its associated health burden, there is a high need to develop therapeutic strategies for patients with this disease. Unfortunately, its long and asymptomatic natural history,
Autor:
Mazen Noureddin, Jean L. Chan, Katherine Barradas, Lara Dimick-Santos, Elmer Schabel, Stephanie O. Omokaro, Frank A. Anania, Robert P. Myers, Veronica Miller, Arun J. Sanyal, Naga Chalasani, Jasmohan Bajaj, Annalisa Berzigotti, Pascal Birman, Jaime Bosch, Ashley Brower, Dania Calboli, William Charlton, Klara Dickinson, Claudia Filozof, Mikael F. Forsgren, Michael Fuchs, Guadalupe Garcia-Tsao, Juan Gonzalez-Abraldes, Hans-Juergen Gruss, Morten Hansen, Suneil Hosman, Joanne Imperial, David Jones, Gadi Lalazar, Olof Dahlqvist Leinhard, Erica Lyons, Brian McColgan, Ruby Mehta, Peter Mesenbrink, Rob Myers, Veronica Pei, Vlad Ratziu, Arie Regev, Robert Riccio, Arun Sanyal, Suna Seo, Alastair Smith, Peter Szitanyi, Peter Traber
Publikováno v:
Gastroenterology. 159(2)
Autor:
Miriam B. Vos, Lara Dimick-Santos, Ruby Mehta, Stephanie O. Omokaro, Johannes Taminiau, Elmer Schabel, David E. Kleiner, Peter Szitanyi, Piotr Socha, Jeffrey B. Schwimmer, Stephanie Noviello, Debra G. Silberg, Richard Torstenson, Veronica Miller, Joel E. Lavine, Nathalie Adda, William Baldyga, Rajarshi Banerjee, Cynthia Behling, Sherif Boulos, Gary Burgess, Dania Calboli, Edgar Charles, Rose Christian, Claude Cohen-Bacrie, Doina Cosma-Roman, Claus-Peter Danzer, Ingrid Delaet, Mark Delegge, Nicholas DiProspero, Kathleen Donohue, Laurent Fischer, Emer Fitzpatrick, Michael Fried, David Hagerty, Paula Hale, Keri Hildick, Dean Hum, Khurram Jamil, Lijuan Jiang, Saul Karpen, Matt Kelly, Rohit Kohli, Kattayoun Kordy, Nancy Krieger, Joel Lavine, Lois Lee, Eric Lefebvre, Patricia Lopez, Erica Lyons, Laura Malahias, Sophie Megnien, Peter Mesenbrink, Pansy Minnick, Christine Murray, Tien Nghiem, Nikki Nicholson, Wenjie Pang, Lisa Percival, Dan Peres, Margaret Powell, Dragos Roman, Mark Root, Claire Sampson, Arun Sanyal, Kathleen Schwarz, Star Seyedkazemi, David Shapiro, Reshma Shringarpure, Debra Silberg, Edward Smith, Robert Squires, William Treem, Pamela Vig, Miriam Vos, Mason Yamashita, Michael Zemel
Publikováno v:
Gastroenterology